BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Prognosis
135 results:

  • 1. Bortezomib in previously treated phosphatase and tension homology-deficient patients with advanced intrahepatic cholangiocarcinoma: An open-label, prospective and single-centre phase II trial.
    Zeng TM; Jiang TY; Yang G; Cheng Z; Lou C; Wei W; Tao CJ; Hu S; Wang H; Cui XW; Tan YX; Dong LW; Wang HY; Yuan ZG
    Clin Transl Med; 2024 May; 14(5):e1675. PubMed ID: 38689424
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Effect of stability of pten on hepatocellular carcinoma.
    Hu Y; Mei H; Luan T; Sun H; Lu Q; Liu R
    J Cancer Res Ther; 2024 Apr; 20(2):726-735. PubMed ID: 38687946
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Exosomal miR-93 derived from hepatocellular carcinoma cell promotes the sorafenib resistance of hepatocellular carcinoma through pten/PI3K/Akt pathway.
    Bao Y; Xu S; Zhou J; Zhao C; Dai S; Zhang Y; Rao M
    J Biochem Mol Toxicol; 2024 Mar; 38(3):e23666. PubMed ID: 38375688
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
    Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
    BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. M2 macrophage-secreted exosomes promote metastasis and increase vascular permeability in hepatocellular carcinoma.
    Lu Y; Han G; Zhang Y; Zhang L; Li Z; Wang Q; Chen Z; Wang X; Wu J
    Cell Commun Signal; 2023 Oct; 21(1):299. PubMed ID: 37904170
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer.
    Gou H; Wong CC; Chen H; Shang H; Su H; Zhai J; Liu W; Liu W; Sun D; Wang X; Yu J
    Cancer Lett; 2023 Dec; 578():216438. PubMed ID: 37827326
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PRL2 inhibition elevates pten protein and ameliorates progression of acute myeloid leukemia.
    Carlock C; Bai Y; Paige-Hood A; Li Q; Nguele Meke F; Zhang ZY
    JCI Insight; 2023 Oct; 8(19):. PubMed ID: 37665633
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Colorectal cancer tumor cell-derived exosomal miR-203a-3p promotes CRC metastasis by targeting pten-induced macrophage polarization.
    Pei W; Wei K; Wu Y; Qiu Q; Zhu H; Mao L; Shi X; Zhang S; Shi Y; Tao S; Mao H; Pang S; Wang J; Liu M; Wang W; Yang Q; Chen C
    Gene; 2023 Nov; 885():147692. PubMed ID: 37562585
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of tumor suppressor genes inactivation on the multidrug resistance phenotype of hepatocellular carcinoma cells.
    Sanchez-Martin A; Sanchon-Sanchez P; Romero MR; Marin JJG; Briz O
    Biomed Pharmacother; 2023 Sep; 165():115209. PubMed ID: 37499450
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma.
    Chong ML; Knight J; Peng G; Ji W; Chai H; Lu Y; Wu S; Li P; Hu Q
    Cancer Genet; 2023 Aug; 276-277():30-35. PubMed ID: 37418972
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The mechanism investigation of mutation genes in liver and lung metastasis of colorectal cancer by using NGS technique.
    Liu K; Cui Y; Li H; Mi J; Wang H; Zhuang Y; Tang L; Liu J; Tian C; Zhang Z; Zhou J; Shi H; Tian X; Liu P
    Crit Rev Oncol Hematol; 2023 Aug; 188():104057. PubMed ID: 37328085
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Primary and secondary angiosarcomas of the liver: a multi-institutional study of 32 cases.
    Liao X; Lai J; Lin J; Zhang D
    Hum Pathol; 2023 Jul; 137():10-17. PubMed ID: 37054784
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. PINK1 Immunoexpression Predicts Survival in Patients Undergoing Hepatic Resection for Colorectal liver Metastases.
    Celis-Pinto JC; Fernández-Velasco AA; Corte-Torres MD; Santos-Juanes J; Blanco-Agudín N; Piña Batista KM; Merayo-Lloves J; Quirós LM; Fernández-Vega I
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047483
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosis.
    Yang Z; Liu J; Xue F; Zhang L; Xue H; Wu Y; Bai S; Du F; Wang X; Deng W; Song C; Wang K
    Ann Hepatol; 2023; 28(2):100898. PubMed ID: 36634747
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. DNA methylation-mediated silencing of Neuronatin promotes hepatocellular carcinoma proliferation through the PI3K-Akt signaling pathway.
    Deng Y; Lu L; Liang X; Li J; Zhu D; Huang H; Zhang Y; Zhang X; Chen Y; Liu X; Fu Y
    Life Sci; 2023 Jan; 312():121266. PubMed ID: 36473542
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Circular RNA ITCH increases sorafenib-sensitivity in hepatocellular carcinoma via sequestering miR-20b-5p and modulating the downstream pten-PI3K/Akt pathway.
    Li X; Yin X; Bao H; Liu C
    Mol Cell Probes; 2023 Feb; 67():101877. PubMed ID: 36442661
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Molecular characterization-based multi-omics analyses in primary liver cancer using the Japanese version of the genome atlas.
    Imamura T; Okamura Y; Ohshima K; Uesaka K; Sugiura T; Yamamoto Y; Ashida R; Ohgi K; Nagashima T; Yamaguchi K
    J Hepatobiliary Pancreat Sci; 2023 Mar; 30(3):269-282. PubMed ID: 35918906
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CFDP1 promotes hepatocellular carcinoma progression through activating NEDD4/pten/PI3K/AKT signaling pathway.
    Zhou Y; Qiu J; Liu S; Wang P; Ma D; Zhang G; Cao Y; Hu L; Wang Z; Wu J; Jiang C
    Cancer Med; 2023 Jan; 12(1):425-444. PubMed ID: 35861040
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. NEK2 promotes the progression of liver cancer by resisting the cellular senescence.
    Lei Q; Xia J; Feng X; Guo J; Li G; Zhou W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):153-164. PubMed ID: 35545405
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Tumor-derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression.
    Luo C; Xin H; Zhou Z; Hu Z; Sun R; Yao N; Sun Q; Borjigin U; Wu X; Fan J; Huang X; Zhou S; Zhou J
    Hepatology; 2022 Oct; 76(4):982-999. PubMed ID: 35106794
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.